切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2021, Vol. 07 ›› Issue (02) : 137 -141. doi: 10.3877/cma.j.issn.2096-1537.2021.02.008

临床研究

ScvO2和Pcv-aCO2在脓毒性休克早期目标指导治疗中的价值
赵国敏1, 陆非平1,()   
  1. 1. 100038 首都医科大学附属北京世纪坛医院重症医学科
  • 收稿日期:2021-01-04 出版日期:2021-05-28
  • 通信作者: 陆非平

Values of central venous oxygen saturation and difference of central venous-arterial partial pressure of carbon dioxide in early goal-directed treatment in patients with septic shock

Guomin Zhao1, Feiping Lu1()   

  1. 1. Department of Critical Care Medicine, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing 100038, China
  • Received:2021-01-04 Published:2021-05-28
  • Corresponding author: Feiping Lu
引用本文:

赵国敏, 陆非平. ScvO2和Pcv-aCO2在脓毒性休克早期目标指导治疗中的价值[J/OL]. 中华重症医学电子杂志, 2021, 07(02): 137-141.

Guomin Zhao, Feiping Lu. Values of central venous oxygen saturation and difference of central venous-arterial partial pressure of carbon dioxide in early goal-directed treatment in patients with septic shock[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2021, 07(02): 137-141.

目的

探讨以中心静脉血氧饱和度(ScvO2)和静脉-动脉血二氧化碳分压差(Pcv-aCO2)为早期目标指导治疗(EGDT)靶点在脓毒性休克治疗中的价值。

方法

采用前瞻性研究方法,选择2018年6月至2020年6月在首都医科大学附属北京世纪坛医院ICU住院治疗的脓毒性休克患者。所有患者入住ICU后立即按脓毒症治疗指南要求给予EGDT治疗。根据转入ICU后6 h的ScvO2及Pcv-aCO2水平将患者分为高Pcv-aCO2组(ScvO2≥0.7且Pcv-aCO2≥6 mmHg,1 mmHg=0.133 kPa);低Pcv-aCO2组(ScvO2 ≥0.7且Pcv-aCO2<6 mmHg)。观察2组患者血流动力学特点、病情严重程度及预后差异。

结果

共入选74例脓毒性休克患者,其中高Pcv-aCO2组28例,低Pcv-aCO2组46例。EGDT后高Pcv-aCO2组较低Pcv-aCO2组心排血指数(CI)、每搏量指数(SVI)明显降低,血管外肺水指数(EVLWI)明显升高;转入ICU后6、24、48 h(T6、T24、T48)急性生理学与慢性健康状况(APACHEⅡ)评分、序贯器官衰竭(SOFA)评分、血乳酸均显著升高;ICU住院时间明显延长,ICU病死率显著增高,差异均有统计学意义(P<0.05)。

结论

脓毒性休克患者ScvO2达标后,以Pcv-aCO2<6 mmHg为EGDT靶点可改善患者的组织灌注及病情严重程度,降低ICU脓毒性休克患者病死率;增加CI可能有助于降低Pcv-aCO2

Objective

To evaluate the value of early goal-directed treatment (EGDT) with the target of central venous oxygen saturation (ScvO2) and difference of central venous–arterial partial pressure of carbon dioxide (Pcv-aCO2) in patients with septic shock.

Methods

A prospective study was conducted from Jun 2018 to Jun 2020 which enrolled 74 septic shock patients admitted to Beijing Shijitan Hospital affiliated Capital Medical University. EGDT was performed in all the patients immediately after enrollment with the target of ScvO2 ≥0.7. All patients were divided into two groups by the values of Pcv-aCO2 at 6 hours after ICU admission. High Pcv-aCO2 group with ScvO2 ≥0.7 and Pcv-aCO2 ≥6 mmHg, Low Pcv-aCO2 group with ScvO2 ≥0.7 and Pcv-aCO2<6 mmHg. Then the parameters of hemodynamics, the acute physiology and chronic health evaluation Ⅱ(APACHEⅡ) score, the sequential organ failure assessment (SOFA) score, lactate and outcome of the patients in different groups were collected.

Results

74 cases were included, among which 28 in high Pcv-aCO2 group and 46 in low Pcv-aCO2 group. Compared with the low Pcv-aCO2 group, the high Pcv-aCO2 group had lower cardiac index (CI) and stroke volume index (SVI), higher extravascular lung water index (EVLWI). The APACHEⅡ score, SOFA score, blood lactate level in high Pcv-aO2 group were significantly higher at 6, 24, 48 hours after ICU admission. The duration of ICU stay, ICU mortality in high Pcv-aCO2 group was significantly higher. The differences were all statistically significant (P<0.05).

Conclusion

Pcv-aCO2<6 mmHg as EGDT target can improve tissue perfusion and severity of patients with septic shock after reaching the standard of ScvO2. Increasing cardiac ejection function may reduce the Pcv-aCO2.

表1 2组脓毒性休克患者基线资料比较
表2 2组脓毒性休克患者EGDT后血流动力学参数比较(
xˉ
±s)
表3 2组脓毒性休克患者疾病严重程度与乳酸水平比较(
xˉ
±s)
表4 2组脓毒性休克患者ICU住院时间及预后指标比较
1
Ebihara I, Hirayama K, Nagai M, et al. Angiopoietin balance in septic shock patients with acute kidney injury: effects of direct hemoperfusion with polymyxin B-immobilized fiber [J]. Ther Apher Dial, 2016, 20(4): 368-375.
2
Wittayachamnankul B, Chentanakij B, Sruamsiri K, et al. The role of central venous oxygen saturation, blood lactate, and central venous-to-arterial carbon dioxide partial pressure difference as a goal and prognosis of sepsis treatment [J]. J Crit Care, 2016, 36: 223-229.
3
中华医学会重症医学分会. 成人严重感染与感染性休克血流动力学监测与支持指南 [J]. 中华内科杂志, 2007, 16(4): 121-126.
4
Beest PAV, Hofstra JJ, Schultz MJ, et al. The incidence of low venous oxygen saturation on admission to the intensive care unit: a multi-center observational study in the Netherlands [J]. Crit Care, 2008, 12(2): R33.
5
Monnet X, Julien F, Ait-Hamou N, et al. Lactate and venoarterial carbon dioxide difference/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders [J]. Crit Care Med, 2013, 41(6): 1412- 1420.
6
高雪花, 李培杰, 曹雯. 中心静脉-动脉二氧化碳分压差与动脉-中心静脉氧含量差的比值联合乳酸清除率指导脓毒症休克早期复苏治疗 [J]. 中华医学杂志, 2018, 98(7): 508-513.
7
Zhou X, Liu D, Su L. Lactate and stepwise lactate kinetics can be used to guide resuscitation [J]. Crit Care, 2017, 21(1): 267.
8
Mallat J, Lemyze M, Meddour M, et al. Ratios of central venous- to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients [J]. Ann Intensive Care, 2016, 6(1): 10.
9
He HW, Liu D, Long Y, et al. High central venous-to-arterial CO2 difference/arterial-central. venous O2 difference ratio is associated with poor lactate clearance in septic patients after resuscitation [J]. J Crit Care, 2016, 31(1): 76-81.
10
Nichols D, Nielsen ND. Oxygen delivery and consumption: microcirculatory. perspective. [J]. Crit Care Clin, 2010, 26(2): 239-253.
11
杜微, 刘大为, 隆云, 等. 静动脉二氧化碳分压差联合上腔静脉血氧饱和度指导休克患者复苏 [J]. 中华医学杂志, 2012, 92(13): 909-914.
12
张青, 王小亭, 张宏民, 等. 重症临床急性生理学学及慢性健康状况系统评分与人工评分的比较 [J].中华医学杂志, 2015, 95(39): 3173-3175.
13
汪颖, 王迪芬, 付江泉, 等. SOFA、qSOFA评分和传统指标对脓毒症预后的判断价值 [J]. 中华危重病急救医学, 2017, 29(8): 700-704.
14
Futier E, Robin E, Jabaudon M, et al. Central venous O2 saturation and venous-to-arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery [J]. Crit Care, 2010, 14(5): 1-11.
15
Cuschieri J, Rivers EP, Donnino MW, et al. Central venous-arterial carbon dioxide difference as an indicator of cardiac index [J]. Intensive Care Med, 2005, 31(6): 818-822.
16
Vallée F, Vallet B, Mathe O, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? [J]. Intensive Care Med, 2008, 34(12): 2218-2225.
[1] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[2] 作者. 脓毒症与脓毒性休克[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(03): 0-0.
[3] 杨新园, 王淑君, 何成, 宋喜鹤, 刘丽芸. 预防与处理危重烧伤患者经外周静脉穿刺置入中心静脉导管堵塞的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 443-446.
[4] 李小龙, 彭飞, 邢虹, 张朋飞, 徐泉, 赵静儒, 李占魁, 郭金珍, 白瑞苗. 局部脑氧饱和度和肠道血氧饱和度对新生儿坏死性小肠结肠炎早期预警及手术治疗时机的指导价值[J/OL]. 中华普通外科学文献(电子版), 2023, 17(01): 45-49.
[5] 唐甜甜, 马力. 中华医学会乳腺癌患者中心静脉血管通路临床实践指南解读[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(03): 240-244.
[6] 康鹏东, 张锴, 张尧, 马超, 韩风. 术中超声辅助下控制性低中心静脉压在大肝癌腔镜切除术中的价值[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(06): 627-630.
[7] 姜东, 冉龙艳, 雷传江, 徐静. 脓毒症的前世今生及序贯器官衰竭认知及理念[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(05): 605-610.
[8] 黄芳芳, 陈雅玫, 邓牡红, 石新华, 尚少梅. 肺癌患者上肢PICC相关性静脉血栓危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(03): 324-328.
[9] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[10] 杨建彬, 陈建华, 张文华, 刘建东. 中心静脉压差值对腹腔镜肝细胞癌肝切除术中出血的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 158-162.
[11] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
[12] 周祥, 张庆庆, 张雪琴, 王晓宇, 姜鸿. Meta分析庆大霉素封管液预防血透患者中心静脉导管相关感染[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 201-206.
[13] 宫平, 刘倩, 王啸, 袁会敏, 王维展, 王璞. 早期PI联合Pv-aCO2/Ca-vO2预测老年脓毒性休克的死亡风险[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 253-258.
[14] 田红梅, 李温荣, 刘俐惠, 张文静. 风险管理联合积极心理护理预防PICC置管患者机械性静脉炎风险的价值[J/OL]. 中华临床医师杂志(电子版), 2022, 16(06): 593-596.
[15] 毛进, 张晨, 高娜, 夏泽燕, 吴宗盛. 脓毒性休克1 h集束化治疗在急诊中的实施情况及预后分析[J/OL]. 中华卫生应急电子杂志, 2023, 09(04): 204-208.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?